References | Study design | Setting (region) | Population Total number of cases | Incidence (/100,000) | ||
---|---|---|---|---|---|---|
Year | Age category (age range) | Serogroup | ||||
EM region | ||||||
 Bahrain [49] | Surveillance study | National surveillance system of communicable diseases (Whole country) | General population N = NR | 1990: 0.83 | Children and adults (0–100 y): 0.83 | All: 0.83 |
 Iran [50] | Cross-sectional study | Data bank at the Center for Disease Control Iran (Whole country) | General population N = 1370 | 2000: 0.67 | Children and adults (0–100 y): 0.67–1.22 | All: 0.67–1.22 |
2001: 1.22 | ||||||
2002: 1.01 | ||||||
2003: 0.73 | ||||||
2004: 0.86 | ||||||
 Kuwait [51] | Surveillance study | All six general hospitals and other subspecialty hospitals (Whole country) | General population N = 293 | 1987–2013: 0.5 | Children and adults (0–100 y): 0.13–0.74 | All: 0.13–0.74 |
1987–1997: 0.74 | ||||||
1998–2008: 0.5 | ||||||
2009–2013: 0.13 | ||||||
 Qatar [52] | Cross-sectional study | Hamad Medical Corporation (Doha) | General population N = 2 | 1998–2000: 0.12 | Children and adults (0–100 y): 0.12 | All: 0.12 |
 Saudi Arabia [53] | Surveillance study | Hospitals with paediatrics services from 5 cities (Al-Jouf, Buraidah, Gateef, Al-Baha, Medina) | General population N = 37 | 1999–2001: 0.0–19.7 | Children (0–5 y): 0.0–19.7 | All: 0.0–19.7 |
 Saudi Arabia [55] | Surveillance study | Laboratories reports from all 20 health regions (Whole country) | General population N = 1103 | 1995–2011: 0.2 | Children and adults (0–100 y): 0.2 | All: 0.2 |
 Saudi Arabia [56] | Cross-sectional study | Saudi Aramco Medical Services Organization (Whole country) | General population N = 10 | 1993–1999: 1.9 | Children and adults (0–100 y): 1.9–2.0 | All: 1.9–2.0 |
2000–2005: 2.0 | ||||||
 Turkey [58] | Surveillance study | 12 paediatric hospitals and clinics (7 regions in Turkey: Central Anatolia, Marmara, South East Anatolia, Aegean, East Anatolia, Mediterranean, Black Sea) | General population N = 85 | 2013: 0.3 | Children (0–17 y): 0.3–0.9 | All: 0.3–0.9 |
2014: 0.9 | ||||||
 Turkey [57] | Surveillance study | 12 paediatric hospitals and clinics (7 regions in Turkey: Central Anatolia, Marmara, South East Anatolia, Aegean, East Anatolia, Mediterranean, Black Sea) | General population N = 333 | 2005–2006: 1.9 | Children (0–17 y): 0.5–1.9 | All: 0.5–1.9 |
2007–2008: 1.5 | ||||||
2009–2010: 0.5 | ||||||
2011–2012: 0.6 | ||||||
 Turkey [59] | Surveillance study | 27 hospitals located in seven regions of Turkey and represented 45 of the population | General population N = 89 | 2015–2016: 0.3 | Children (0–18 y): 0.3–0.4 | All: 0.3–0.4 |
2017–2018: 0.4 | ||||||
 Yemen [60] | Cross-sectional study | Al-Salam hospital (Sana’a) | General population N = 81 | 2000: 8.8–20.5 | Children (0–15 y): 8.8–20.5 | All: 8.8–20.5 |
 Saudi Arabia [54] | Surveillance study | Records (Ministry of Health and regional health directorates), clinical laboratory records and inpatient charts (hospitals) (Mecca, Medina, Jeddah) | Pilgrims N = 253 Hajj study, outbreak study | January–June 2000: 5.8–8.9 | Children and adults (0–80 y): 5.8–8.9 | A: 5.8 |
W135: 8.9 | ||||||
NA region | ||||||
 Egypt [61] | Surveillance study | MOHP (Whole country) | General population N = NR | 1967–1992: 0.7–2.0 1992–2003: 0.1 | Children and adults (0–100 y): 0.1–2.0 | All: 0.1–2.0 |
 Egypt [62] | Cross-sectional study | Communicable Disease Hospital (Alexandria) | General population N = 314 | 1997–2006: 1.06 | Children and adults (0–100 y): 1.06 | All: 1.06 |
 Morocco [63] | Surveillance study | Epidemiology of the Health Systems Networks Service (Kenitra delegation) | General population N = 29 | 2014–2018: 2.96 | Children and adults (0–100 y): 2.11–3.75 | All: 2.11–3.75 |
2014: 3.59 | ||||||
2015: 2.79 | ||||||
2016: 2.11 | ||||||
2017: 2.53 | ||||||
2018: 3.75 | ||||||
 Tunisia [64] | Cross-sectional study | Bechir Hamza Children’s Hospital (Tunis) | General population N = 73 | 2014: 1.5 | Children (0–18 y): 1.5 | All: 1.5 |